Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
March 10, 2015 |

Latham, Kirkland Face Off in Hostile Bid for Retail REIT

Latham & Watkins is advising Simon Property Group Inc. in its $22.4 billion hostile bid for retail real estate investment trust The Macerich Company, which has turned to Kirkland & Ellis for counsel.
2 minute read
March 10, 2015 | Law.com

Latham, Kirkland Face Off in Hostile Bid for Retail REIT

Latham & Watkins is advising Simon Property Group Inc. in its $22.4 billion hostile bid for retail real estate investment trust The Macerich Company, which has turned to Kirkland & Ellis for counsel.
2 minute read
February 27, 2015 |

Dealmaker of the Week: Alison Ressler of Sullivan & Cromwell

A corporate partner at Sullivan & Cromwell, Ressler advised Valeant Pharmaceuticals International Inc. in its $10.1 billion acquisition of Raleigh, North Carolina-based Salix Pharmaceuticals Ltd.
5 minute read
February 27, 2015 | Law.com

Dealmaker of the Week: Alison Ressler of Sullivan & Cromwell

A corporate partner at Sullivan & Cromwell, Ressler advised Valeant Pharmaceuticals International Inc. in its $10.1 billion acquisition of Raleigh, North Carolina-based Salix Pharmaceuticals Ltd.
5 minute read
February 26, 2015 |

Deal Watch: Sullivan & Cromwell Advise Valeant on $10.1 Billion Buy of Salix

Our latest roundup of deals worth $1 billion or more includes Valeant Pharmaceuticals International Inc.'s purchase of Salix Pharmaceuticals Ltd. for $10.1 billion; Asahi Kasei Corp.'s buy of Polypore International Inc. in a deal valued at $3.2 billion; and a merger between silicon producers Grupo FerroAtlántica and Globe Specialty Metals Inc. for a combined value of $3.1 billion. Latham & Watkins advised on the most number of deals, with four, while Sullivan & Cromwell led the way in terms of transaction value.
5 minute read
February 26, 2015 | Law.com

Deal Watch: Sullivan & Cromwell Advise Valeant on $10.1 Billion Buy of Salix

Our latest roundup of deals worth $1 billion or more includes Valeant Pharmaceuticals International Inc.'s purchase of Salix Pharmaceuticals Ltd. for $10.1 billion; Asahi Kasei Corp.'s buy of Polypore International Inc. in a deal valued at $3.2 billion; and a merger between silicon producers Grupo FerroAtlántica and Globe Specialty Metals Inc. for a combined value of $3.1 billion. Latham & Watkins advised on the most number of deals, with four, while Sullivan & Cromwell led the way in terms of transaction value.
5 minute read
February 26, 2015 |

Big Deals

Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash.
3 minute read
February 25, 2015 | Law.com

Big Deals

Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash.
3 minute read
February 01, 2015 |

February Deals & Suits

11 minute read
January 20, 2015 | Law.com

February Deals & Suits

Actavis Allergan After seven months of resisting a takeover bid from Canada's Valeant Pharmaceuticals International, Allergan Inc. agreed on Nov. 17…
11 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources